Search

Your search keyword '"Farkkila, M"' showing total 151 results

Search Constraints

Start Over You searched for: Author "Farkkila, M" Remove constraint Author: "Farkkila, M"
151 results on '"Farkkila, M"'

Search Results

1. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

2. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

3. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

4. Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

5. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles

6. Survival after antireflux surgery versus medication in patients with reflux oesophagitis or Barrett's oesophagus:multinational cohort study

7. Trait components provide tools to dissect the genetic susceptibility of migraine

10. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. (Inflammatory Bowel Disease)

12. Genetic architecture of human plasma lipidome and its link to cardiovascular disease

13. Genetic architecture of human plasma lipidome and its link to cardiovascular disease

17. Immunohistochemical study of neuroendocrine cells at the gastric cardia mucosa. (Original Article)

18. Foveolar hyperplasia at the gastric cardia: prevalence and associations. (Original Article)

19. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.

20. Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.

22. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

23. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine (vol 48, pg 856, 2016)

24. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

25. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

26. Multicenter randomized trial comparing short-term stenting versus balloon dilatation for dominant strictures in primary sclerosing cholangitis

28. A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3

29. A Genome-wide Scan Identifies a Genetic Locus for Migraine with Aura

31. Validation of the Prognostic Value of Histologic Scoring Systems in Primary Sclerosing Cholangitis; A Multicenter Cohort Study

32. Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial

33. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1

34. Cerebrospinal fluid findings in multiple sclerosis patients before, during and after pregnancy

35. O5 PRIMARY SCLEROSING CHOLANGITIS FROM A GLOBAL PERSPECTIVE – A MULTICENTER, RETROSPECTIVE, OBSERVATIONAL STUDY OF THE INTERNATIONAL PSC STUDY GROUP

36. Impact of Obesity on the Bioavailability of Peginterferon-alpha 2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3

37. Health-related quality of life in secondary progressivemultiple sclerosis

38. A visual migraine aura locus maps to 9q21-q22

42. Almotriptan and zolmitriptan in the acute treatment of migraine

47. Author's reply

Catalog

Books, media, physical & digital resources